Literature DB >> 24117347

AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.

Jocelyn J Lippman-Bell1, Sanjay N Rakhade, Peter M Klein, Makram Obeid, Michele C Jackson, Annelise Joseph, Frances E Jensen.   

Abstract

PURPOSE: To determine whether AMPA receptor (AMPAR) antagonist NBQX can prevent early mammalian target of rapamycin (mTOR) pathway activation and long-term sequelae following neonatal seizures in rats, including later-life spontaneous recurrent seizures, CA3 mossy fiber sprouting, and autistic-like social deficits.
METHODS: Long-Evans rats experienced hypoxia-induced neonatal seizures (HS) at postnatal day (P)10. NBQX (20 mg/kg) was administered immediately following HS (every 12 h × 4 doses). Twelve hours post-HS, we assessed mTOR activation marker phosphorylated p70-S6 kinase (p-p70S6K) in hippocampus and cortex of vehicle (HS + V) or NBQX-treated post-HS rats (HS + N) versus littermate controls (C + V). Spontaneous seizure activity was compared between groups by epidural cortical electroencephalography (EEG) at P70-100. Aberrant mossy fiber sprouting was measured using Timm staining. Finally, we assessed behavior between P30 and P38. KEY
FINDINGS: Postseizure NBQX treatment significantly attenuated seizure-induced increases in p-p70S6K in the hippocampus (p < 0.01) and cortex (p < 0.001). Although spontaneous recurrent seizures increased in adulthood in HS + V rats compared to controls (3.22 ± 1 seizures/h; p = 0.03), NBQX significantly attenuated later-life seizures (0.14 ± 0.1 seizures/h; p = 0.046). HS + N rats showed less aberrant mossy fiber sprouting (115 ± 8.0%) than vehicle-treated post-HS rats (174 ± 10%, p = 0.004), compared to controls (normalized to 100%). Finally, NBQX treatment prevented alterations in later-life social behavior; post-HS rats showed significantly decreased preference for a novel over a familiar rat (71.0 ± 12 s) compared to controls (99.0 ± 15.6 s; p < 0.01), whereas HS + N rats showed social novelty preference similar to controls (114.3 ± 14.1 s). SIGNIFICANCE: Brief NBQX administration during the 48 h postseizure in P10 Long-Evans rats suppresses transient mTOR pathway activation and attenuates spontaneous recurrent seizures, social preference deficits, and mossy fiber sprouting observed in vehicle-treated adult rats after early life seizures. These results suggest that acute AMPAR antagonist treatment during the latent period immediately following neonatal HS can modify seizure-induced activation of mTOR, reduce the frequency of later-life seizures, and protect against CA3 mossy fiber sprouting and autistic-like social deficits. Wiley Periodicals, Inc.
© 2013 International League Against Epilepsy.

Entities:  

Keywords:  AMPA receptor antagonists; Autistic-like behavior; Early life seizures; Epileptogenesis; Hypoxic/ischemic encephalopathy

Mesh:

Substances:

Year:  2013        PMID: 24117347      PMCID: PMC4262152          DOI: 10.1111/epi.12378

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  69 in total

1.  Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.

Authors:  I Jambaqué; C Chiron; C Dumas; J Mumford; O Dulac
Journal:  Epilepsy Res       Date:  2000-02       Impact factor: 3.045

2.  Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat.

Authors:  Bo Zhang; Michael Wong
Journal:  Epilepsia       Date:  2012-01-13       Impact factor: 5.864

3.  Neural correlates of face and object recognition in young children with autism spectrum disorder, developmental delay, and typical development.

Authors:  Geraldine Dawson; Leslie Carver; Andrew N Meltzoff; Heracles Panagiotides; James McPartland; Sara J Webb
Journal:  Child Dev       Date:  2002 May-Jun

Review 4.  The neurology of autism spectrum disorders.

Authors:  Shafali S Jeste
Journal:  Curr Opin Neurol       Date:  2011-04       Impact factor: 5.710

5.  Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.

Authors:  Emily K Osterweil; Dilja D Krueger; Kimberly Reinhold; Mark F Bear
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

6.  Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex.

Authors:  Marco Cambiaghi; Marco Cursi; Laura Magri; Valerio Castoldi; Giancarlo Comi; Fabio Minicucci; Rossella Galli; Letizia Leocani
Journal:  Neuropharmacology       Date:  2012-11-14       Impact factor: 5.250

7.  Mammalian target of rapamycin complex 1 activation negatively regulates Polo-like kinase 2-mediated homeostatic compensation following neonatal seizures.

Authors:  Hongyu Sun; Bela Kosaras; Peter M Klein; Frances E Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

8.  Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.

Authors:  Sanjay N Rakhade; Chengwen Zhou; Paven K Aujla; Rachel Fishman; Nikolaus J Sucher; Frances E Jensen
Journal:  J Neurosci       Date:  2008-08-06       Impact factor: 6.167

Review 9.  Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.

Authors:  Michael Wong
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

Review 10.  Neonatal seizures.

Authors:  Faye S Silverstein; Frances E Jensen
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

View more
  23 in total

1.  Regulation of seizure-induced MeCP2 Ser421 phosphorylation in the developing brain.

Authors:  Evan C Rosenberg; Jocelyn J Lippman-Bell; Marcus Handy; Samantha S Soldan; Sanjay Rakhade; Cristina Hilario-Gomez; Kaitlyn Folweiler; Leah Jacobs; Frances E Jensen
Journal:  Neurobiol Dis       Date:  2018-05-05       Impact factor: 5.996

2.  Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice.

Authors:  John J McMahon; Wilson Yu; Jun Yang; Haihua Feng; Meghan Helm; Elizabeth McMahon; Xinjun Zhu; Damian Shin; Yunfei Huang
Journal:  Neurobiol Dis       Date:  2014-10-12       Impact factor: 5.996

3.  Effects of AMPA receptor antagonist, NBQX, and extrasynaptic GABAA agonist, THIP, on social behavior of adolescent and adult rats.

Authors:  Carol A Dannenhoffer; Elena I Varlinskaya; Linda Patia Spear
Journal:  Physiol Behav       Date:  2018-05-22

4.  AMPA Receptor Dysregulation and Therapeutic Interventions in a Mouse Model of CDKL5 Deficiency Disorder.

Authors:  Madhumita Yennawar; Rachel S White; Frances E Jensen
Journal:  J Neurosci       Date:  2019-04-05       Impact factor: 6.167

5.  Transcriptome analysis of rat dorsal hippocampal CA1 after an early life seizure induced by kainic acid.

Authors:  Heather O'Leary; Lauren Vanderlinden; Lara Southard; Anna Castano; Laura M Saba; Tim A Benke
Journal:  Epilepsy Res       Date:  2020-01-30       Impact factor: 3.045

6.  Early-life seizures alter synaptic calcium-permeable AMPA receptor function and plasticity.

Authors:  Jocelyn J Lippman-Bell; Chengwen Zhou; Hongyu Sun; Joel S Feske; Frances E Jensen
Journal:  Mol Cell Neurosci       Date:  2016-08-10       Impact factor: 4.314

7.  Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy.

Authors:  Delia M Talos; Leah M Jacobs; Sarah Gourmaud; Carlos A Coto; Hongyu Sun; Kuei-Cheng Lim; Timothy H Lucas; Kathryn A Davis; Maria Martinez-Lage; Frances E Jensen
Journal:  Ann Neurol       Date:  2018-02-15       Impact factor: 10.422

8.  Early life seizures: evidence for chronic deficits linked to autism and intellectual disability across species and models.

Authors:  Paul B Bernard; Tim A Benke
Journal:  Exp Neurol       Date:  2014-10-02       Impact factor: 5.330

9.  Enhanced long term potentiation and decreased AMPA receptor desensitization in the acute period following a single kainate induced early life seizure.

Authors:  Heather O'Leary; Paul B Bernard; Anna M Castano; Tim A Benke
Journal:  Neurobiol Dis       Date:  2015-12-17       Impact factor: 5.996

10.  Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.

Authors:  Sarah Gourmaud; Haochang Shou; David J Irwin; Kimberly Sansalone; Leah M Jacobs; Timothy H Lucas; Eric D Marsh; Kathryn A Davis; Frances E Jensen; Delia M Talos
Journal:  Brain       Date:  2020-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.